Total Payments
$81,865
2024 Payments
$6,951
Companies
29
Transactions
75
Medicare Patients
198
Medicare Billing
$61,145
Payment Breakdown by Category
Research$38,344 (46.8%)
Consulting$27,168 (33.2%)
Travel$13,642 (16.7%)
Food & Beverage$1,673 (2.0%)
Other$1,000.00 (1.2%)
Education$37.47 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $38,344 | 11 | 46.8% |
| Consulting Fee | $27,168 | 14 | 33.2% |
| Travel and Lodging | $13,642 | 4 | 16.7% |
| Food and Beverage | $1,673 | 42 | 2.0% |
| Grant | $1,000 | 1 | 1.2% |
| Education | $37.47 | 3 | 0.0% |
Payments by Type
General
$43,520
64 transactions
Research
$38,344
11 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $37,192 | 1 | $0 (2020) |
| F. Hoffmann-La Roche AG | $23,088 | 9 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $7,519 | 3 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $5,073 | 4 | $0 (2022) |
| Tempus AI, Inc | $2,159 | 6 | $0 (2024) |
| Daiichi Sankyo Inc. | $2,020 | 10 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,082 | 9 | $0 (2019) |
| Merck Sharp & Dohme LLC | $1,073 | 3 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $900.00 | 1 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $582.80 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,951 | 27 | F. Hoffmann-La Roche AG ($3,420) |
| 2023 | $22,836 | 15 | F. Hoffmann-La Roche AG ($19,668) |
| 2022 | $4,651 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($4,590) |
| 2020 | $39,692 | 5 | Eli Lilly and Company ($37,192) |
| 2019 | $1,456 | 14 | GlaxoSmithKline, LLC. ($1,082) |
| 2018 | $6,197 | 8 | Ipsen Biopharmaceuticals, Inc ($5,055) |
| 2017 | $83.12 | 2 | Celgene Corporation ($70.63) |
All Payment Transactions
75 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Sandoz Inc. | — | Food and Beverage | In-kind items and services | $33.34 | General |
| 11/05/2024 | F. Hoffmann-La Roche AG | — | Consulting Fee | Cash or cash equivalent | $2,660.00 | General |
| 10/15/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Oncology | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 09/25/2024 | PFIZER INC. | XYNTHA (Biological), BENEFIX, BEQVEZ | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: HEMATOLOGY | ||||||
| 09/10/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/03/2024 | Fennec Pharmaceuticals, Inc. | Pedmark (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Cisplatin-induced Ototoxicity | ||||||
| 08/28/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: ONCOLOGY | ||||||
| 07/30/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: ONCOLOGY | ||||||
| 07/16/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Oncology | ||||||
| 07/15/2024 | F. Hoffmann-La Roche AG | — | Consulting Fee | Cash or cash equivalent | $760.00 | General |
| 07/03/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $10.78 | General |
| 06/19/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.28 | General |
| 06/19/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: ONCOLOGY | ||||||
| 06/06/2024 | Octapharma USA, Inc. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: IMMUNOLOGY | ||||||
| 06/05/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Oncology | ||||||
| 06/02/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $39.53 | General |
| 05/30/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $30.67 | General |
| Category: NONE | ||||||
| 05/17/2024 | BeiGene USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $458.33 | General |
| 05/16/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: ONCOLOGY | ||||||
| 05/01/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $22.31 | General |
| Category: Hematology | ||||||
| 04/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: ONCOLOGY | ||||||
| 04/22/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $83.79 | General |
| 03/28/2024 | Tempus AI, Inc | — | Consulting Fee | Cash or cash equivalent | $1,475.00 | General |
| 03/28/2024 | Tempus AI, Inc | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 1 MULTICENTER GLOBAL FIRST IN HUMAN STUDY OF THE CD73 INHIBITOR LY3475070 AS MONOTHERAPY OR IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED SOLID MALIGNANCIES | Eli Lilly and Company | $37,192 | 1 |
| MASTER PROTOCOL TO ASSESS THE SAFETY AND ANTITUMOR ACTIVITY OF GENETIC | GlaxoSmithKline, LLC. | $1,082 | 9 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 56 | 115 | $30,874 | $8,457 |
| 2020 | 4 | 142 | 469 | $170,139 | $52,688 |
Total Patients
198
Total Services
584
Medicare Billing
$61,145
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 97 | $24,250 | $6,638 | 27.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 18 | $6,624 | $1,819 | 27.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 58 | 203 | $76,697 | $23,675 | 30.9% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 29 | 189 | $69,363 | $21,632 | 31.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 37 | 59 | $16,483 | $5,074 | 30.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 18 | 18 | $7,596 | $2,307 | 30.4% |
About Dr. Shiraj Sen, M.D
Dr. Shiraj Sen, M.D is a Internal Medicine healthcare provider based in Irving, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/07/2012. The National Provider Identifier (NPI) number assigned to this provider is 1770842155.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shiraj Sen, M.D has received a total of $81,865 in payments from pharmaceutical and medical device companies, with $6,951 received in 2024. These payments were reported across 75 transactions from 29 companies. The most common payment nature is "" ($38,344).
As a Medicare-enrolled provider, Sen has provided services to 198 Medicare beneficiaries, totaling 584 services with total Medicare billing of $61,145. Data is available for 2 years (2020–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Medical Oncology, Hematology & Oncology
- Location Irving, TX
- Active Since 05/07/2012
- Last Updated 04/04/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1770842155
Products in Payments
- Onivyde (Drug) $5,055
- GILOTRIF (Drug) $2,929
- Stivarga (Drug) $900.00
- IMFINZI (Biological) $525.00
- Enhertu (Drug) $400.22
- PRECISETUMOR (Device) $138.40
- IBRANCE (Drug) $37.47
- XT CDX (Device) $30.67
- Tecentriq (Biological) $30.00
- Pedmark (Drug) $24.04
- Polivy (Biological) $24.03
- QINLOCK (Drug) $23.61
- ZENPEP (Drug) $23.33
- VERZENIO (Drug) $23.03
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) $22.85
- REBLOZYL (Biological) $22.31
- MEKINIST (Drug) $22.09
- ENJAYMO (Biological) $21.76
- Lenvima (Drug) $20.81
- Phesgo (Biological) $20.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Irving
Dr. Samata Basani, M.d, M.D
Internal Medicine — Payments: $302,290
Internal Medicine $302,290
Branden Snyder, M.d, M.D
Internal Medicine — Payments: $29,735
Internal Medicine $29,735
Ahmed Iqbal, M.d, M.D
Internal Medicine — Payments: $24,674
Internal Medicine $24,674
Nauman Siddiqi, Md, MD
Internal Medicine — Payments: $19,851
Internal Medicine $19,851
Dr. Enid Romanelli, M.d, M.D
Internal Medicine — Payments: $14,115
Internal Medicine $14,115
Dr. Gilberto Jimenez-Justiniano, M.d, M.D
Internal Medicine — Payments: $11,985
Internal Medicine $11,985